50-112-9771

CD279 (PD-1) Monoclonal Antibody (RMP1-30), PE, eBioscience™, Invitrogen™

Manufacturer: Fischer Scientific

Select a Size

Pack Size SKU Availability Price
Each 50-112-9771-Each In Stock ₹ 21,239.85

50-112-9771 - Each

₹ 21,239.85

In Stock

Quantity

1

Base Price: ₹ 21,239.85

GST (18%): ₹ 3,823.173

Total Price: ₹ 25,063.023

Antigen

CD279 (PD-1)

Classification

Monoclonal

Concentration

0.2 mg/mL

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Accession No.

Q02242

Gene Symbols

Pdcd1

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

18566

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

RMP1-30

Conjugate

PE

Gene

Pdcd1

Gene Alias

CD279; EGK_05005; hPD1; hPD-1; hPD-l; hSLE1; Ly101; mPD-1; PD1; PD-1; Pdc1; Pdcd1; programmed cell death 1; programmed cell death 1 protein; programmed cell death protein 1; programmed cell death protein 1-like; programmed death 1; Protein PD1; protein PD-1; sCD279; SLEB2; soluble CD279; systemic lupus erythematosus susceptibility 2

Host Species

Rat

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Mouse

Product Type

Antibody

Isotype

IgG2b κ

Related Products

Img

Fischer Scientific

50-112-9395

--

Img

Fischer Scientific

50-113-37

--

Img

Fischer Scientific

50-112-9178

--

Img

Fischer Scientific

50-112-9702

--

Img

Fischer Scientific

50-112-9281

--

Img

Fischer Scientific

50-139-56

--

Img

Fischer Scientific

50-123-09

--

Img

Fischer Scientific

50-113-29

--

Description

  • Description: The RMP1-30 antibody reacts with mouse PD-1 (programmed death-1), a 55 kDa member of the Ig superfamily
  • PD-1 contains the immunoreceptor tyrosine-based inhibitory motif (ITIM) and plays a key role in peripheral tolerance and autoimmune disease in mice
  • PD-1 is expressed mainly on activated T and B lymphocytes
  • Two novel B7 Family members have been identified as PD-1 ligands, PD-L1 (B7-H1) and PD-L2 (B7-DC)
  • Evidence reported to date suggests overlapping functions for these ligands and their constitutive expression on some normal tissues and upregulation on activated antigen-presenting cells
  • RMP1-30 does not block the binding of either B7-H1-Ig or B7-DC-Ig to PD-1 transfectants
  • Applications Reported: The RMP1-30 antibody has been reported for use in flow cytometric analysis
  • Applications Tested: This RMP1-30 antibody has been tested by flow cytometric analysis of Con A-stimulated mouse splenocytes
  • This can be used at less than or equal to 1 μg per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest
  • Excitation: 488-561 nm; Emission: 578 nm; Laser: Blue Laser, Green Laser, Yellow-Green Laser
  • Filtration: 0.2 μm post-manufacturing filtered
  • Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC)
  • T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC
  • PD-1 can bind two different but related ligands, PDL-1 and PDL-2
  • Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of &quotedanger signals&quote such as LPS or other molecules associated with bacteria or other pathogens
  • Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases
  • Despite its predicted molecular weight, PD-1 often migrates at higher molecular weight in SDS-PAGE.